(Q39622212)

13 September 2017

title

The costs of rheumatoid arthritis. a patient-oriented study of chronic disease costs (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

23 November 2022

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A100122

23 November 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

23 November 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

23 November 2022

author name string

R. F. Meenan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A100122

23 November 2022

E. H. Yelin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A100122

23 November 2022

C. J. Henke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A100122

23 November 2022

D. L. Curtis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A100122

23 November 2022

W. V. Epstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A100122

23 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=100122

23 November 2022

publication date

1 September 1978

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780210714

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780210714

23 November 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

23 November 2022

published in

Arthritis & Rheumatology

1 reference

13 September 2017

Arthritis and Rheumatism

21

7

827–33

September 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=100122

23 November 2022

volume

21

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

827-833

1 reference

The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FART.1780210714

Therapeutic criteria in rheumatoid arthritis

21 January 2018

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

Therapeutic criteria in rheumatoid arthritis

23 November 2022

11

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

Earnings of early diagnosed arthritis patients and matched controls

23 November 2022

13

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

Rheumatoid arthritis in a New England town. A prevalence study in Sudbury, Massachusetts

23 November 2022

15

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

The university rheumatic disease clinic: provider and patient receptions of cost

23 November 2022

17

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

The Quarterly Journal of Medicine

23 November 2022

21

43

205

Lee

1974

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

Comprehensive outpatient care in rheumatoid arthritis. A controlled study

23 November 2022

22

1 reference

https://api.crossref.org/works/10.1002/ART.1780210714

23 November 2022

Identifiers

1 reference

13 September 2017

1 reference